Morgan Stanley Maintains Overweight on Endava, Lowers Price Target to $68
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst James Faucette has maintained an Overweight rating on Endava (NYSE:DAVA) but lowered the price target from $72 to $68.

September 20, 2023 | 12:20 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Endava's price target has been lowered from $72 to $68 by Morgan Stanley, though the Overweight rating is maintained.
The lowering of the price target by Morgan Stanley could potentially create a negative sentiment among investors, but the maintained Overweight rating indicates that the firm still sees the stock as a good investment. This mixed signal could lead to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100